Cargando…
The Current State of Targeted Agents in Rectal Cancer
Targeted biologic agents have an established role in treating metastatic colorectal cancer (CRC), and the integration of targeted therapies into the treatment of CRC has resulted in significant improvements in outcomes. Rapidly growing insight into the molecular biology of CRC, as well as recent dev...
Autores principales: | Kim, Dae Dong, Eng, Cathy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3362864/ https://www.ncbi.nlm.nih.gov/pubmed/22675625 http://dx.doi.org/10.1155/2012/406830 |
Ejemplares similares
-
Robotic‐assisted surgery for rectal cancer: Current state and future perspective
por: Matsuyama, Takatoshi, et al.
Publicado: (2018) -
Current Molecular Targeted Agents for Advanced Gastric Cancer
por: Nie, Shanshan, et al.
Publicado: (2020) -
Current debate in the oncologic management of rectal cancer
por: Millard, Trish, et al.
Publicado: (2016) -
An Update on Preoperative Radiotherapy for Locally Advanced Rectal Cancer
por: Yeo, Seung-Gu, et al.
Publicado: (2012) -
Current status of surgical treatment of rectal cancer in China
por: Yang, Yong, et al.
Publicado: (2020)